Prolonged response after the discontinuation of nivolumab after resistance to gefitinib. [electronic resource]
Producer: 20200311Description: 657-658 p. digitalISSN:- 1752-699X
- Adenocarcinoma of Lung -- diagnostic imaging
- Adrenal Insufficiency -- chemically induced
- Aged
- Antineoplastic Agents, Immunological -- administration & dosage
- Central Nervous System Neoplasms -- secondary
- Gefitinib -- therapeutic use
- Genes, erbB-1 -- genetics
- Humans
- Lung Neoplasms -- diagnostic imaging
- Male
- Mutation
- Nivolumab -- administration & dosage
- Protein Kinase Inhibitors -- therapeutic use
- Treatment Outcome
- Withholding Treatment
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.